Related Experiment Videos
[Surgical treatment for massive pulmonary embolism]
Ivan Aleksic1, Markus Kamler, Ulf Herold
1Klinik für Thorax- und Kardiovaskuläre Chirurgie, Westdeutsches Herzzentrum Essen, Universitätsklinikum Essen, Hufelandstrasse 55, 45122, Essen. ivan.aleksic@uni-essen.de
Herz
|June 21, 2005
Summary
Surgical embolectomy for massive pulmonary embolism (PE) is a rare but effective last-chance option. Improved techniques show high survival rates, warranting further study against thrombolytic therapy.
Area of Science:
- Cardiovascular Surgery
- Pulmonary Medicine
- Critical Care Medicine
Context:
- Massive pulmonary embolism (PE) treatment has shifted towards thrombolytic therapy.
- Surgical embolectomy is often considered a last resort.
- Thrombolytic therapy can lead to residual obstruction and chronic pulmonary hypertension.
Purpose:
- To evaluate the resurgence and efficacy of surgical embolectomy for massive PE.
- To compare surgical embolectomy outcomes with thrombolytic therapy.
- To advocate for randomized controlled trials to establish best practices.
Summary:
- Surgical embolectomy, performed with extracorporeal circulation (ECC) support on a beating heart, is showing renewed promise.
- Reported perioperative survival rates reach up to 89% in select patients.
- The procedure is effective in patients with stable hemodynamics but significant right ventricular dysfunction.
Impact:
- Surgical embolectomy offers a viable alternative for patients with massive PE, especially those with residual obstruction post-thrombolysis.
- Improved surgical techniques and risk stratification are enhancing patient outcomes.
- Further randomized trials are needed to solidify the role of surgical embolectomy in achieving optimal patient care.